IGC Pharma (IGC) Stock: Buy, Sell, or Hold?

IGC - IGC Pharma, Inc.

PHARMACEUTICAL PREPARATIONS
$0.27
0.00 (1.81%) ▲
5d: -2.66%
30d: -7.1%
90d: -2.17%
HOLD
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 13, 2026

Get Alerted When IGC Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 HOLD: IGC shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: IGC is currently trading at $0.27, which is considered fair relative to its 30-day fair value range of $0.27 to $0.30.

Technical Outlook: Technically, IGC is in a uptrend. Immediate support is located at $0.27, while resistance sits at $0.30.

Market Sentiment: IGC scores 74/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $6.00 (+2082.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position FAIR
Historical Trading Range $0.27 - $0.30
Company Quality Score 64/100 (BUY)
Volume Confirmation HIGH
Confidence Score 86.8%

All Signals

  • NEUTRAL: Price in fair range
  • BULLISH: Strong technical setup (74/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 2082.6% below Wall St target ($6.00)
  • CAUTION: Bottoming setup, but lagging the sector by 22% over 20 days — wait for relative strength

Trading Range Analysis

30-Day Trading Range $0.27 - $0.30
Current vs Trading Range FAIR

Support & Resistance Levels

Support Level $0.27
Resistance Level $0.30
Current Trend Uptrend
Technical data as of Oct 2, 2026

Fundamental Context

Forward P/E (Next Year Est.) -3.05
Wall Street Target $6.00 (+2082.6%)
Revenue Growth (YoY) -19.2%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: October 03, 2026 10:38 PM ET
Data refreshes hourly during market hours. Next update: 11:38 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ALNY
Alnylam Pharmaceuticals …
STRONG BUY
30 analysts
$371 49 HOLD
ONC
BeiGene, Ltd.
STRONG BUY
24 analysts
$433 56 HOLD
VRTX
Vertex Pharmaceuticals I…
BUY
34 analysts
$570 55 HOLD
ASND
Ascendis Pharma AS
STRONG BUY
16 analysts
$310 66 BUY
CLDX
Celldex Therapeutics Inc
STRONG BUY
15 analysts
$63 60 BUY

More Analysis for IGC

IGC Technical Chart IGC Price Prediction IGC Earnings Date IGC Investment Advisor IGC Fair Price Analyzer IGC Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals